Bleichroeder LP’s 2seventy bio TSVT Stock Holding History

Bleichroeder LP’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-255,230	Closed	-$2.58M	–	82
2023 Q2	$2.58M	Buy	255,230 +89,823	+54%	+$951K	0.52%	26
2023 Q1	$1.69M	Buy	+165,407	New	+$1.89M	0.36%	27

Other funds holding TSVT

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Bleichroeder LP's TSVT Position: Q3 2023 in Review

Bleichroeder LP sold out of 2seventy bio (TSVT) in Q3 2023, closing a stake of 255,230 shares — an estimated $2.58M sold.

Bleichroeder LP first reported a position in TSVT in Q1 2023 and held it in 2 quarters. The position peaked at $2.58M in Q2 2023. 146 funds tracked by Wall St. Rank hold TSVT as of Q3 2023.

Bleichroeder LP reported no remaining 2seventy bio position as of Q3 2023 after selling out during the quarter.
Bleichroeder LP sold 255,230 2seventy bio shares in Q3 2023, an estimated $2.58M.
Bleichroeder LP first reported a position in 2seventy bio in Q1 2023 and held it in 2 quarters.
Bleichroeder LP's 2seventy bio position peaked at $2.58M in Q2 2023.
146 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2023.

Based on Bleichroeder LP's 13F filing for Q3 2023, filed 9 Nov 2023.